Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Feb 24, 2022
Open Peer Review Period: Feb 24, 2022 - Apr 21, 2022
Date Accepted: May 12, 2022
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Using Artificial Intelligence as a Diagnostic Decision Support Tool in Skin Disease: Protocol for an Observational Prospective Cohort Study

Escalè Besa A, Fuster-Casanovas A, Bröve A, Yélamos Pena O, Fustà Novell X, Esquius Rafat M, Marin X, Vidal-Alaball J

Using Artificial Intelligence as a Diagnostic Decision Support Tool in Skin Disease: Protocol for an Observational Prospective Cohort Study

JMIR Res Protoc 2022;11(8):e37531

DOI: 10.2196/37531

PMID: 36044249

PMCID: 9475422

Using artificial intelligence as a diagnostic decision support tool in skin disease: observational prospective cohort study

  • Anna Escalè Besa; 
  • Aïna Fuster-Casanovas; 
  • Alexander Bröve; 
  • Oriol Yélamos Pena; 
  • Xavier Fustà Novell; 
  • Mireia Esquius Rafat; 
  • Xavier Marin; 
  • Josep Vidal-Alaball

ABSTRACT

Background:

Dermatological conditions are a relevant health problem. Machine learning models are increasingly being applied to dermatology as a diagnostic decision support tool using image analysis, especially for skin cancer detection and classification.

Objective:

The objective of this study is to perform a prospective validation of an image analysis Machine Learning (ML) model, which is capable of screening 44 different skin disease types, comparing its diagnostic capacity with that of General Practitioners (GPs) and dermatologists.

Methods:

In these prospective study 100 consecutive patients who visit a participant GP with a skin problem in central Catalonia will be recruited, data collection is planned to last 7 months. Skin diseases anonymized pictures will be taken and introduced in the ML model interface, which will return top 5 accuracy diagnosis. The same image will be also sent as a teledermatology consultation, following the current workflow. GP, ML model and dermatologist/s assessments will be compared to calculate the precision, sensitivity, specificity and accuracy of the ML model.

Results:

Results will be represented globally and individually for each skin disease class using a confusion matrix and One vs All methodology. Time taken to make the diagnosis will also be taken into consideration.

Conclusions:

This study will provide information about ML models effectiveness and limitations. External testing is essential for regulating these diagnostic systems, in order to deploy ML models in a PCP setting. Clinical Trial: The clinical trial has been approved by the IDIAP Jordi Gol i Guirna ethics committee with code 20-159P


 Citation

Please cite as:

Escalè Besa A, Fuster-Casanovas A, Bröve A, Yélamos Pena O, Fustà Novell X, Esquius Rafat M, Marin X, Vidal-Alaball J

Using Artificial Intelligence as a Diagnostic Decision Support Tool in Skin Disease: Protocol for an Observational Prospective Cohort Study

JMIR Res Protoc 2022;11(8):e37531

DOI: 10.2196/37531

PMID: 36044249

PMCID: 9475422

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.